M&A strategy
Goals of M&A
As our strategy for the future, we are actively engaged in establishing our own unique businesses and in making corporate acquisitions to increase sales of our businesses other than human resource business.
Basic M&A policies
Acquiring 100% of a company's stock is our basic principle. On the premise that we can leverage our knowledge and experience in research in the physical sciences and our know-how in the business fields that define our company - namely chemistry, bioengineering-related fields, drug manufacture-related fields, certain areas of engineering, and CRO-related fields - in we will make a direct approach via WDB Business Succession Partners to the companies that we feel will contribute to the our group synergy. Following merger and acquisition, we will incorporate a company as a subsidiary into our growth strategy, with our sights set on unlimited growth and development.
Results of M&A
| No. | Month / Year | Business field | Description |
|---|---|---|---|
| 1 | Sep. 2003 | Human resource business | Purchased the rights to operate branches of Human West Co., Ltd. in Okayama, Hiroshima, Takamatsu and Tokushima. |
| 2 | Mar. 2005 | Human resource business | Genomic Brain is made a wholly-owned subsidiary through share acquisition. |
| 3 | Jul. 2008 | Human resource business | Acquired the business rights to Santoku Life Co., Ltd. |
| 4 | Oct. 2008 | R&D / Manufacturing (Chemical) | Kilo Technology Research Laboratory Co., Ltd. (WDB Functional Chemistry Co., Ltd.) is made a wholly-owned subsidiary through share acquisition. ※Dissolution in December 2018 |
| 5 | Jan. 2009 | R&D / Manufacturing(Bioengineering) |
Acquired the fixed assets of Tasaki Co., Ltd. and established an environmental / biology research facility. ※Transfered all shares in December 2018 |
| 6 | Apr. 2011 | CRO | Used stock acquisition to make ICO Co., Ltd. (Now WDB coco Co., Ltd.) a wholly-owned subsidiary. |
| 7 | Mar. 2013 | CRO |
Used a stock acquisition to make Densuke Systems Ltd. (WDB Clinical Research Co., Ltd.) a wholly-owned subsidiary.
※Acquired and merged by WDB coco Co.,Ltd. in June 2023. |
| 8 | Apr. 2014 | R&D / Manufacturing(Engineering) |
Kaken Geneqs Co., Ltd. made a wholly-owned subsidiary through share acquisition. ※Transfered all shares in February 2022 |
| 9 | Mar. 2017 | CRO | Oy Medfiles Ltd. made a wholly-owned subsidiary through share acquisition. |
| 10 | Jun. 2017 | CRO | Cobridge Co., Ltd. made a wholly-owned subsidiary through share acquisition. |
| 11 | Aug. 2018 | CRO |
A subsidiary WDB Medical Data, Inc. used stock acquisition to make DZS Software Solutions, Inc. a wholly-owned subsidiary.
※DZS Software Solutions, Inc. changed its brand name from DZS Clinical Services to Medfiles USA in January 2023. |